These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 18040780)

  • 41. Role of MIP-1beta and RANTES in HIV-1 infection of microglia: inhibition of infection and induction by IFNbeta.
    Kitai R; Zhao ML; Zhang N; Hua LL; Lee SC
    J Neuroimmunol; 2000 Oct; 110(1-2):230-9. PubMed ID: 11024554
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Human immunodeficiency virus and the brain.
    Glass JD; Johnson RT
    Annu Rev Neurosci; 1996; 19():1-26. PubMed ID: 8833434
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Neuropathology and neurodegeneration in HIV infection.
    Jellinger KA
    Clin Neuropathol; 2001; 20(6):276-7. PubMed ID: 11758784
    [No Abstract]   [Full Text] [Related]  

  • 44. A coat of many colors: neuroimmune crosstalk in human immunodeficiency virus infection.
    Kraft-Terry SD; Buch SJ; Fox HS; Gendelman HE
    Neuron; 2009 Oct; 64(1):133-45. PubMed ID: 19840555
    [TBL] [Abstract][Full Text] [Related]  

  • 45. gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors.
    Catani MV; Corasaniti MT; Navarra M; Nisticò G; Finazzi-Agrò A; Melino G
    J Neurochem; 2000 Jun; 74(6):2373-9. PubMed ID: 10820198
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pathways to neuronal injury and apoptosis in HIV-associated dementia.
    Kaul M; Garden GA; Lipton SA
    Nature; 2001 Apr; 410(6831):988-94. PubMed ID: 11309629
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Human immunodeficiency virus infection and acquired immunodeficiency syndrome dementia complex: role of cells of monocyte-macrophage lineage.
    Aquaro S; Ronga L; Pollicita M; Antinori A; Ranazzi A; Perno CF
    J Neurovirol; 2005; 11 Suppl 3():58-66. PubMed ID: 16540457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. HIV-1 and its causal relationship to immunosuppression and nervous system disease in AIDS: a review.
    Sotrel A; Dal Canto MC
    Hum Pathol; 2000 Oct; 31(10):1274-98. PubMed ID: 11070121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. In situ amplification and detection of HIV-1 DNA in fixed pediatric AIDS brain tissue.
    Sharer LR; Saito Y; Da Cunha A; Ung PC; Gelbard HA; Epstein LG; Blumberg BM
    Hum Pathol; 1996 Jun; 27(6):614-7. PubMed ID: 8666375
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Patterns of selective neuronal damage in methamphetamine-user AIDS patients.
    Langford D; Adame A; Grigorian A; Grant I; McCutchan JA; Ellis RJ; Marcotte TD; Masliah E;
    J Acquir Immune Defic Syndr; 2003 Dec; 34(5):467-74. PubMed ID: 14657756
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Central Nervous System Inflammation and Infection during Early, Nonaccelerated Simian-Human Immunodeficiency Virus Infection in Rhesus Macaques.
    Hsu DC; Sunyakumthorn P; Wegner M; Schuetz A; Silsorn D; Estes JD; Deleage C; Tomusange K; Lakhashe SK; Ruprecht RM; Lombardini E; Im-Erbsin R; Kuncharin Y; Phuang-Ngern Y; Inthawong D; Chuenarom W; Burke R; Robb ML; Ndhlovu LC; Ananworanich J; Valcour V; O'Connell RJ; Spudich S; Michael NL; Vasan S
    J Virol; 2018 Jun; 92(11):. PubMed ID: 29563297
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [HIV encephalopathy and neural stem cell virology].
    Miura Y; Kitayama H; Andou Y; Koyanagi Y
    No To Shinkei; 2006 Jul; 58(7):553-9. PubMed ID: 16910464
    [No Abstract]   [Full Text] [Related]  

  • 53. Pathogenesis of human immunodeficiency virus-induced neurological disease.
    Albright AV; Soldan SS; González-Scarano F
    J Neurovirol; 2003 Apr; 9(2):222-7. PubMed ID: 12707852
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Type I Interferons in NeuroHIV.
    Thaney VE; Kaul M
    Viral Immunol; 2019; 32(1):7-14. PubMed ID: 30260742
    [TBL] [Abstract][Full Text] [Related]  

  • 55. HIV-associated neurocognitive disorder: pathogenesis and therapeutic opportunities.
    Lindl KA; Marks DR; Kolson DL; Jordan-Sciutto KL
    J Neuroimmune Pharmacol; 2010 Sep; 5(3):294-309. PubMed ID: 20396973
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Human immunodeficiency virus type 1 infection of the nervous system: pathogenetic mechanisms.
    Epstein LG; Gendelman HE
    Ann Neurol; 1993 May; 33(5):429-36. PubMed ID: 8498818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Neuropathology and neurodegeneration in human immunodeficiency virus infection. Pathogenesis of HIV-induced lesions of the brain, correlations with HIV-associated disorders and modifications according to treatments.
    Gray F; Adle-Biassette H; Chretien F; Lorin de la Grandmaison G; Force G; Keohane C
    Clin Neuropathol; 2001; 20(4):146-55. PubMed ID: 11495003
    [TBL] [Abstract][Full Text] [Related]  

  • 58. HIV-associated dementia: new insights into disease pathogenesis and therapeutic interventions.
    Swindells S; Zheng J; Gendelman HE
    AIDS Patient Care STDS; 1999 Mar; 13(3):153-63. PubMed ID: 10375263
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The neuropathology of adult HIV infection.
    Bell JE
    Rev Neurol (Paris); 1998 Dec; 154(12):816-29. PubMed ID: 9932303
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Aids dementia complex. On the relationship between HIV-1 infection, immune-mediated response and myelin damage in the brain.
    Mastroianni CM; Liuzzi GM; Riccio P
    Acta Neurol (Napoli); 1991 Apr; 13(2):184-7. PubMed ID: 1891984
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.